Key facts
- Notable investors include Shenzhen Capital Group, Detong Capital, Teda VC, Granary Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Ysmile
- ·The full record, as it builds
Funding rounds
No funding rounds for Ysmile are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ysmile
Manufacturer of interventional medical instruments designed to treat cardiovascular diseases through minimally invasive implantation. The company offers varicose vein sealing gel, tumour embolisation microspheres, femoral artery occluders, and a structured pipeline spanning embolisation, blocking, filling, and expansion systems, enabling hospitals and interventional cardiologists to perform targeted vascular therapies with improved procedural precision and clinical effectiveness.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2020
- Ownership
- Privately Held (backing)
Ysmile doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ysmile shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ysmile in its N-PORT filings yet. We sweep new filings monthly.